Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, has won the CMO Award for Life Science Leadership in Drug Delivery, during the Drug, Chemical and Associated Technologies Association (DCAT) week at New York.

Nanomi's pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare.

Dr. Shahin Fesharaki, Global Chief Scientific Officer, Lupin said, “This recognition underscores our dedication to advancing science and highlights Nanomi's pioneering efforts in drug delivery. We remain committed to innovation that enables the delivery of high-quality medicines that significantly improve patient outcomes.”

Established in 2011, the CMO Leadership Awards are presented by Outsourced Pharma and Life Science Connect with research by Orientation Marketing and recognize top outsourcing partners, based on the feedback from sponsor companies who outsource manufacturing. This year is the first year that the CMO Leadership Award is juried.